The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. [electronic resource]
Producer: 20141224Description: 961-70 p. digitalISSN:- 2168-6157
- Aged
- Aged, 80 and over
- Alzheimer Disease -- diagnosis
- Amyloid beta-Peptides -- metabolism
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Apolipoprotein E4 -- genetics
- Clinical Trials as Topic -- standards
- Cognition Disorders -- diagnosis
- Disease Progression
- Early Diagnosis
- Executive Function -- physiology
- Feasibility Studies
- Female
- Heterozygote
- Humans
- Male
- Memory, Episodic
- Middle Aged
- Neuropsychological Tests -- standards
- Positron-Emission Tomography
- Prodromal Symptoms
- Prospective Studies
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.